Erratum: Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer: The Phase III PACIFIC-2 Study
Journal of Clinical Oncology · 10.02.2026 · 44 (5) · 429-429
DOI: 10.1200/jco-25-03012 ↗Kurz gefasst
Korrektur in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.02.2026. Verfasst von Jeffrey D Bradley und 15 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bradley, J. D., Sugawara, S., Lee, K. H., Ostoros, G., Demirkazik, A., Zemanova, M., Sriuranpong, V., Zimmer Gelatti, A. C., Janoski de Menezes, J., Zurawski, B., Newton, M., Chander, P., Jia, N., Bielecka, Z. F., Özgüroğlu, M., & PACIFIC-2 Investigators (2026). Erratum: Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer: The Phase III PACIFIC-2 Study. Journal of Clinical Oncology, 44(5), 429-429. https://doi.org/10.1200/jco-25-03012
Vancouver
Bradley JD, Sugawara S, Lee KH, Ostoros G, Demirkazik A, Zemanova M, et al. Erratum: Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer: The Phase III PACIFIC-2 Study. Journal of Clinical Oncology. 2026;44(5):429-429. doi:10.1200/jco-25-03012
BibTeX
@article{Bradley2026,
author = {Bradley, Jeffrey D and Sugawara, Shunichi and Lee, Ki Hyeong and Ostoros, Gyula and Demirkazik, Ahmet and Zemanova, Milada and Sriuranpong, Virote and Zimmer Gelatti, Ana Caroline and Janoski de Menezes, Juliana and Zurawski, Bogdan and Newton, Michael and Chander, Pratibha and Jia, Nan and Bielecka, Zofia F and Özgüroğlu, Mustafa and PACIFIC-2 Investigators, PACIFIC-2 Investigators},
title = {Erratum: Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer: The Phase III PACIFIC-2 Study},
journal = {Journal of Clinical Oncology},
year = {2026},
volume = {44},
number = {5},
pages = {429--429},
doi = {10.1200/jco-25-03012}
}
EUVIMED